Hopp til hovedinnhold

Nevrocysticercose

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Delgado-García G, Méndez-Zurita VA, Bayliss L, Flores-Rivera J, Fleury A. Neurocysticercosis: mimics and chameleons. Pract Neurol. 2018. pmid:30282762 PubMed  
  2. Garcia HH. Neurocysticercosis. Neurol Clin. 2018; Nov;36(4):: 851-864. pmid:30366559 PubMed  
  3. Bustos J, Gonzales I, Saavedra H, Handali S, Garcia HH; Cysticercosis Working Group in Peru. Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world. J Neurol Sci. 2021 Aug 15;427:117527. PMID: 34147957. PubMed  
  4. Del Brutto OH. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med. 2012 Mar-Apr;19(2):112-7 . pmid: 22414036 PubMed  
  5. Svrckova P, Nabarro L, Chiodini PL, Jäger HR. Disseminated cerebral hydatid disease (multiple intracranial echinococcosis). Pract Neurol. 2019 Apr;19(2):156-163. PMID: 30305379 PubMed  
  6. Webb CM, White AC Jr. Update on the Diagnosis and Management of Neurocysticercosis. Curr Infect Dis Rep. 2016 Dec;18( . pmid:27787774 PubMed  
  7. Dhesi B, Karia SJ, Adab N, Nair S. Imaging in neurocysticercosis. Pract Neurol 2015. pmid:25425681 PubMed  
  8. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 2014; 12: 1202-15. pmid:25453460 PubMed  
  9. Carpio A, et al. New diagnostic criteria for neurocysticercosis: Reliability and validity. Ann Neurol. 2016 Sep;80(3):434-42. pmid:27438337 PubMed  
  10. Del Brutto OH. Diagnostic criteria for neurocysticercosis. Ann Neurol. 2016 Oct 12. pmid:27730674 PubMed  
  11. Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, Vasquez CM, Salgado P, Gilman RH, Garcia HH. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017 Jan 15;372:202-210. pmid: 28017213 PubMed  
  12. Iwama K, Mizuguchi T, Takanashi JI, Shibayama H, Shichiji M, Ito S, Oguni H, Yamamoto T, Sekine A, Nagamine S, Ikeda Y, Nishida H, Kumada S, Yoshida T, Awaya T, Tanaka R, Chikuchi R, Niwa H, Oka YI, Miyatake S, Nakashima M, Takata A, Miyake N, Ito S, Saitsu H, Matsumoto N. . Identification of novel SNORD118 mutations in seven patients with leukoencephalopathy with brain calcifications and cysts. Clin Genet. 2017. pmid:28177126 PubMed  
  13. Sharma M, Singh T, Mathew A.. Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database Syst Rev. 2015 Oct 12;10:CD009027 . pmid:26455722 PubMed  
  14. Hamamoto Filho PT, Fragoso G, Sciutto E, Fleury A. Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions. Expert Rev Anti Infect Ther. 2021 Apr 9:1-16. PMID: 33794119. PubMed  
  15. Anand P, Mukerji SS, Thon J, Gunaratne S, Cho TA, Venna N. Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 20;6(6) PMID: 31454762 PubMed  
  16. Monk EJM, Abba K, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD000215. PMID: 34060667 PubMed  
  17. Johnson N, Saini AG, Malhi P, Khandelwal N, Singhi P. Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children. J Child Neurol. 2021 Oct 12:8830738211035864. PMID: 34641721. PubMed  
  18. Sankhyan N, Kadwa RA, Kamate M, Kannan L, Kumar A, Passi GR, Sharawat IK, Singhi P; For Association of Child Neurology Delphi Group for Neurocysticerosis in Childhood. Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines. Indian Pediatr. 2021 Sep 15;58(9):871-880. PMID: 34338221. PubMed  
  19. Frackowiak M, Sharma M, Singh T, et al. Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database Syst Rev. 2019 Oct 14;10:CD009027. doi: 10.1002/14651858.CD009027.pub3. The Cochrane Library  
  20. Abraham A, Bustos JA, Carabin H, de Meijere R, Sahu PS, Rajshekhar V, Singh G, White AC Jr, Chiodini PL, Gabriël S, Homeida M, Nash T, Ngowi B, Zhou XN, Coyle C, Garcia HH, Winkler AS. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations. PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009193. PMID: 33788843 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med